3rd Edition of
International Ophthalmology Conference
March 10-12, 2025 | Rome, Italy
Ophthalmology Research and Novel Approaches
Ophthalmology is a medical specialty that focuses on the diagnosis and treatment of eye disorders and abnormalities. The human eye's purpose is to receive visual information. Because of the availability and development of novel in vivo imaging tools, there has been tremendous progress in the general knowledge of ocular disorders during the previous ten years. The therapy procedures have been influenced by recent improvements in diagnostic methods. Many intriguing advancements in ophthalmology, particularly anterior segment technologies, have occurred in recent years. Imaging has become crucial in the detection and treatment of diseases affecting the back of the eye. Imaging systems for the anterior segment have gained popularity in recent years and are now commonly employed in clinical practice.
- Diagnostic and Therapeutic Innovations
- Recent Trends in Ophthalmology
- Clinical Observations
- Case Studies
John David Bullock
Wright State University, United States
Minckler Don S
UCI Gavin Herbert Eye Institute, United States
Kasra Rezaei
University of Washington, United States
Dhruva Drew Gupta
Harvard Medical School, United States
Nour Abou Shousha
Harvard Medical School, United States
George HH Beiko
McMaster Univeresity, Canada
Mustafa Al Ghazi
University Hospital of Wales, United KingdomSubmit your abstract Today
Title : Optic nerve orthograde axonal transport in abusive head trauma suspects
Minckler Don S, UCI Gavin Herbert Eye Institute, United States
Title : Eyes and guts connection: Microbiomes and their role in ocular health
Edward Charles Kondrot, Healing the Eye Wellness Center, United States
Title : Ultra-Widefield protocol enhances automated classification of diabetic retinopathy severity with OCT angiography
Kasra Rezaei, University of Washington, United States
Title : Why was Leonhard Euler blind?
John David Bullock, Wright State University, United States
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : Developing resilience-based treatments for glaucoma
Simon John, Columbia University, United States